Crinetics Pharmaceuticals, Inc. — All Filings
655 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0001950047-25-007529 | Sep 26, 2025 | — |
| 8-K | 8-K | 0001658247-25-000008 | Sep 26, 2025 | Sep 25, 2025 |
| SCHEDULE 13G | — | 0000908834-25-000292 | Sep 8, 2025 | — |
| 4 | 4 | 0001948238-25-000009 | Sep 4, 2025 | Sep 2, 2025 |
| 144 | — | 0001950047-25-006667 | Sep 2, 2025 | — |
| 4 | 4 | 0001948238-25-000007 | Aug 26, 2025 | Aug 22, 2025 |
| 144 | — | 0001950047-25-006266 | Aug 22, 2025 | — |
| 4 | 4 | 0001948238-25-000005 | Aug 21, 2025 | Aug 20, 2025 |
| 144 | — | 0001950047-25-006116 | Aug 20, 2025 | — |
| SCHEDULE 13G/A | — | 0000902219-25-000287 | Aug 12, 2025 | — |
| 8-K | 8-K | 0001193125-25-175494 | Aug 7, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-175498 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-091613 | Jun 30, 2025 | — |
| 8-K | 8-K | 0000950170-25-090405 | Jun 26, 2025 | — |
| 4 | 4 | 0000950170-25-086804 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | 4 | 0000950170-25-086269 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086260 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086268 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086267 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086264 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086265 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086266 | Jun 13, 2025 | Jun 11, 2025 |
| 8-K | 8-K | 0000950170-25-085442 | Jun 12, 2025 | Jun 11, 2025 |
| 144 | — | 0001950047-25-004220 | Jun 12, 2025 | — |
| DEFA14A | DEFA14A | 0000950170-25-074707 | May 20, 2025 | — |
| 4 | 4 | 0000950170-25-073605 | May 16, 2025 | May 14, 2025 |
| SCHEDULE 13G/A | — | 0000315066-25-001470 | May 12, 2025 | — |
| 8-K | 8-K | 0000950170-25-066939 | May 8, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-066982 | May 8, 2025 | Mar 31, 2025 |
| DEFA14A | DEFA14A | 0000950170-25-057462 | Apr 23, 2025 | — |
| ARS | ARS | 0000950170-25-057467 | Apr 23, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0000950170-25-057452 | Apr 23, 2025 | Jun 11, 2025 |
| SCHEDULE 13G/A | — | 0000932471-25-000397 | Apr 7, 2025 | — |
| 8-K | 8-K | 0000950170-25-051179 | Apr 4, 2025 | Apr 1, 2025 |
| 4 | 4 | 0000950170-25-051170 | Apr 4, 2025 | Apr 2, 2025 |
| 4 | 4 | 0000950170-25-043407 | Mar 21, 2025 | Mar 19, 2025 |
| 4 | 4 | 0000950170-25-043404 | Mar 21, 2025 | Mar 19, 2025 |
| 4 | 4 | 0000950170-25-043401 | Mar 21, 2025 | Mar 19, 2025 |
| 4 | 4 | 0000950170-25-043402 | Mar 21, 2025 | Mar 19, 2025 |
| 4 | 4 | 0000950170-25-037200 | Mar 11, 2025 | Mar 10, 2025 |
| 3 | 3 | 0000950170-25-033698 | Mar 5, 2025 | Feb 28, 2025 |
| 8-K | 8-K | 0000950170-25-029040 | Feb 27, 2025 | — |
| 10-K | 10-K | 0000950170-25-029050 | Feb 27, 2025 | Dec 31, 2024 |
| S-8 | S-8 | 0000950170-25-029087 | Feb 27, 2025 | — |
| 4 | 4 | 0000950170-25-025664 | Feb 24, 2025 | Feb 20, 2025 |
| 8-K | 8-K | 0000950170-25-025248 | Feb 24, 2025 | Feb 21, 2025 |
| 4 | 4 | 0000950170-25-025665 | Feb 24, 2025 | Feb 20, 2025 |
| 4 | 4 | 0000950170-25-025666 | Feb 24, 2025 | Feb 20, 2025 |
| 4 | 4 | 0000950170-25-025667 | Feb 24, 2025 | Feb 20, 2025 |
| SCHEDULE 13G/A | — | 0000902219-25-000051 | Feb 10, 2025 | — |